Ijpd 24 345
Ijpd 24 345
Ijpd 24 345
Alireza Shamsoddini*1, PhD; Susan Amirsalari2, MD; Mohammad-Taghi Hollisaz1, MD; Alireza Rahimnia3, MD;
Amideddin Khatibi-Aghda1, MD
1Exercise Physiology Research Center, 2Department of Pediatric Neurology, 3Department of Orthopedic Surgery,
Baqiyatallah University of Medical Sciences, Tehran, Iran
Received: Jan 10, 2014; Accepted: Feb 17, 2014; First Online Available: May 09, 2014
Abstract
Cerebral palsy is the most common cause of spasticity and physical disability in children and spasticity is one
of the commonest problems in those with neurological disease. The management of spasticity in children with
cerebral palsy requires a multidisciplinary effort and should be started as early as possible. There are a
number of treatments available for the management of spasticity. This article reviews the variety of options
available for the clinical management of spasticity.
Iranian Journal of Pediatrics, Volume 24 (Number 4), August 2014, Pages: 345-351
Key Words: Cerebral Palsy; Intrathecal Baclofen; Occupational Therapy; Physical Therapy; Rhizotomy; Spasticity
* Corresponding Author;
Address: Exercise Physiology Research Center, Baqiyatallah University Medical Sciences, Tehran, Iran
E-mail: alirezaot@bmsu.ac.ir
2014 by Pediatrics Center of Excellence, Childrens Medical Center, Tehran University of Medical Sciences, All rights reserved.
Selective dorsal rhizotomy flexion through the use of AFOs has been found to
improve walking efficiency in children with
Selective dorsal rhizotomy (SDR) derives from late spastic diplegic cerebral palsy[33] and in children
19th century procedures for spasticity. SDR is a with hemiplegic cerebral palsy. When AFO use is
neurosurgical procedure that involves partial compared to barefoot walking, the children's
sensory deafferentation at the levels of L1 through walking patterns are better when wearing
S2 nerve rootlets[26]. After a series of tone AFOs[34]. For children with cerebral palsy who
management with rehabilitation punctuated with tend to walk on their toes, AFOs have been shown
botulinum toxin injections, the child would to improve their ability to move from sit to stand.
probably be around 4 to 5 years old and SDR can However, children with cerebral palsy who are
be considered. A suitable candidate for selective able to stand on a flat foot did not benefit from
dorsal rhizotomy is typified by 1) spasticity is still AFOs for moving from sit to stand as the AFOs
a problem 2) good strength of lower limbs and tended to slow them down[35]. AFOs have also
trunk muscles 3) able to stand straight with good been shown to affect how much energy children
alignment 4) intellectually good enough for with cerebral palsy use to walk. One study found
carrying out training[27]. that children with spastic diplegic cerebral palsy
had lower oxygen needs during walking when
they wore hinged AFOs[36].
hypertonia in childhood. Pediatrics 2003;111(1): 26. Park TS. Selective dorsal rhizotomy for the
e89-97. spasticity of cerebral palsy. In: Rengachery SS,
9. Lundy C, Lumsden D, Fairhurst C. Treating complex Wilkins RH, editors. Neurosurgical Operative Atlas.
movement disorders in children with cerebral palsy. Park Ridge, IL: American Association of Neurological
Ulster Med J 2009;78(3):157-63. Surgeons; 1994; Pp: 183-90.
10. Amirsalari S, Dalvand H, Dehghan L, et al. The 27. Chan NNC. Physiotherapy in Spasticity Management
efficacy of botulinum toxin type A injection in the for Children with Cerebral Palsy. Hong Kong Med
hamstring and calf muscles with and without serial Bulletin 2011;16(7):24-6.
foot casting in gait improvement in children with 28. Christopher M. Orthotic Management of Children
cerebral palsy. Tehran Uni Med J 2011;69(8):509-17. with Cerebral Palsy. JPO Online Library 2002;14(4):
11. Meythaler JM. Concept of spastic hypertonia. Phys 150-8.
Med Rehabil Clin N Am 2001; 12(4):725-32. 29. Teplicky R, Law M, Russell D. The effectiveness of
12. Dalvand H, Dehghan L, Feizy A, et al. The effect of casts, orthoses, and splints for children with
foot serial casting along with botulinum toxin type-a neurological disorders. Infants Young Child 2002;
injection on spasticity in children with cerebral 15(1):42-50.
palsy. J Kerman Uni Med Sci 2012;19(6):562-73. [in 30. Shashi R, Das SP, Gursimrat SC. Efficacy of occu-
Persian] pational therapy and serial casting in lower limbs of
13. Mandigo CE, Anderson RC. Management of cerebral palsy children administered with phenol
childhood spasticity: a neurosurgical perspective. nerve block. J Clin Orthop Trauma 2011;2(1):39-45.
Pediatr Ann 2006;35(5):354-62. 31. Hinderer KA, Harris SR, Purdy AH, et al. Effects of
14. Beukelman DR, Mirenda P. Augmentative and 'tone-reducing' vs. standard plaster-casts on gait
Alternative Communication: Management of Severe improvement of children with cerebral palsy. Dev
Communication Disorders in Children and Adults. Med Child Neurol 1988;30(3):370-7.
(2nd ed). Baltimore: Brookes Publishing. 1999; 32. Gok H, Kucukdeveci A, Altinkaynak H, et al. Effects of
Pp:246-9. ankle-foot orthoses on hemiparetic gait. Clin Rehabil
15. Berker N, Yalin S (eds). The HELP Guide to Cerebral 2003;17(2):137-9.
Palsy, 2nd ed. Washington, USA: Global Help. 2010; 33. Crenshaw S, Herzog R, Castagno P, et al. The efficacy
Pp: 30-3. of tone-reducing features in orthotics on the gait of
16. Ashworth B. Preliminary trial of carisoprodol in children with spastic diplegic cerebral palsy.
multiple sclerosis. Practitioner 1964;192:540-2. J Pediatr Orthop 2000;20(2):210-6.
17. Tilton AH. Management of spasticity in children with 34. Buckon CE, Sienko Thomas S, Jakobson-Huston S, et
cerebral palsy. Semin Pediatr Neurol 2004;11(1):58- al. Comparison of three ankle-foot orthosis
65. configurations for children with spastic hemiplegia.
Dev Med Child Neurol 2001;43(6):371-8.
18. Matthews DJ, Balaban B. Management of spasticity
in children with cerebral palsy. Acta Orthop 35. Wilson H, Haideri N, Song K, et al. Ankle-foot
Traumatol Turc 2009;43(2):81-6. orthoses for perambulatory children with spastic
diplegia. J Pediatr Orthop 1997;17(3):370-6.
19. Chung CY, Chen CL, Wong AM. Pharmacotherapy of
spasticity in children with cerebral palsy. J Formos 36. Maltais D, Bar-Or O, Galea V, et al. Use of orthoses
Med Assoc 2011;110(4):215-22. lowers the O2 cost of walking in children with
spastic cerebral palsy. Med Sci Sports Exerc 2000;
20. Kinnett D. Botulinum toxin A injections in children: 33(2):320-5.
technique and dosing issues. Am J Phys Med Rehabil
2004; 83(Suppl 10):S59-64. 37. Gage J, Gormley Jr M, Krach L, et al. Managing
spasticity in children with cerebral palsy requires a
21. Jefferson RJ. Botulinum toxin in the management of team approach. a pediatric perspective. Gillette
cerebral palsy. Dev Med Child Neurol 2004; 46(7): Children Spatiality Health Care 2004;13(3):3-5.
491-9.
38. Dodd K, Imms C, Taylor NF (eds). Physiotherapy and
22. Yang TF, Fu CP, Kao NT, et al. Effect of botulinum Occupational Therapy for People with Cerebral
toxin type A on cerebral palsy with upper limb Palsy: A Problem-Based Approach to Assessment
spasticity. Am J Phys Med Rehabil 2003; 82(4):284-9. and Management. 1st ed. London: British library
23. Russman BS, Tilton A, Gormley ME Jr. Cerebral cataloguing in-publication data. 2010; Pp:177- 90.
palsy: a rational approach to a treatment protocol, 39. Levitt S. Proprioceptive neuromuscular facilitation
and the role of botulinum toxin in treatment. Muscle techniques in cerebral palsy. Physiotherapy 1966;
Nerve Suppl 1997; 6:S181-93. 52(2):46-51.
24. Roche N, Even-Schneider A, Bussel B, et al. 40. Hastings-Smith R, Sharpe M. Brunnstrom therapy: is
Management of increase in spasticity in patients it still relevant to stroke rehabilitation? Physio
with intrathecal baclofen pumps. Ann Readapt Med Theory Pract 1994;10:87-94.
Phys 2007; 50(2):93-9.
41. Price R, Lehmann JF, Boswell-Bessette S, et al.
25. Mess SA, Kim S, Davison S, et al. Implantable Influence of cryotherapy on spasticity of the human
baclofen pump as an adjuvant in treatment of ankle. Arch Phys Med Rehabil 1993; 74(3):300-4.
pressure sores. Ann Plast Surg 2003; 51(5):465-7.
42. Lehmann JF, deLateur BJ. Therapeutic Heat. In: and walking in children with spastic diplegia. Iran J
Lehman JF (edittor): Therapeutic Heat and Cold. 3rd Child Neurol 2013;7(4):12-9.
ed. Baltimore: Williams & Wilkins. 1982; Pp: 110-9. 48. Gracies JM. Pathophysiology of impairment in
43. Hinderer SR, Dixon K. Physiologic and clinical patients with spasticity and the use of stretch as a
monitoring of spastic hypertonia. Phys Med Rehabil treatment of spastic hypertonia. Phys Med Rehabil
Clin N Am 2001;12(4):733-46. Clin N Am 2001;12(4):747-68.
44. Rassafiani M, Sahaf R. Hypertonicity in children with 49. David A, Alan L. Orthoses in the Management of
cerebral palsy: a new perspective. IRJ 2011; 9(0): Spasticity in the Lower Limb. ACNR 2006;6(2):35-6.
66-74. 50. Pirpiris M, Graham HK. Management of spasticity in
45. Dalvand H, Dehghan L, Feizy A, et al. Effect of the children. In: Barnes MP, Johnson GR (editors):
Bobath technique, conductive education and Upper motor neuron syndrome and spasticity:
education to parents in activities of daily living in Clinical management and neurophysiology.
children with cerebral palsy in Iran. Hong Kong Cambridge: Cambridge University Press; 2001; Pp:
J Occup Ther 2009;19(1):14-9. 266-305.
46. Cusick A, McIntyre S, Novak I, et al. A comparison of 51. Colangelo C. Biomechanical frame of reference. In:
goal attainment scaling and the Canadian Kramer P, Hinojosa J (editors): Frames of Reference
Occupational Performance Measure for paediatric for Pediatric Occupational Therapy. 2nd ed.
rehabilitation research. Dev Neurorehabil 2006; Philadelphia: Williams & Wilkins; 1999; Pp:257-322.
9(2):149-57. 52. Khalid AM, Sabahat AW. Management of spastic
47. Dalvand H, Dehghan L, Feizi A, et al. The impacts of cerebral palsy in the UAE: An overview. ACNR 2009;
hinged and solid ankle-foot orthoses on standing 9(2):30-2.